A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.
Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence / Tefferi, A; Al Ali, H. K; Barosi, G; Devos, T; Gisslinger, H; Jiang, Q; Kiladjian, J. J; Mesa, R; Passamonti, F; Mcmullin, M. F; Ribrag, V; Schiller, G; Vannucchi, ALESSANDRO MARIA; Zhou, D; Reiser, D; Zhong, J; Gale, R. P.. - In: LEUKEMIA. - ISSN 0887-6924. - ELETTRONICO. - 31:(2017), pp. 1252-1252. [10.1038/leu.2017.2]
Erratum: A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence
VANNUCCHI, ALESSANDRO MARIA;
2017
Abstract
A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
leukemia pomalid.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
35.39 kB
Formato
Adobe PDF
|
35.39 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
